Otolaryngology & rhinology
Rhinitis medicamentosa from chronic oxymetazoline use is common and under-treated, because cold-turkey discontinuation, INCS monotherapy, and turbinate reduction do not address alpha-adrenoceptor tachyphylaxis during the withdrawal window. Concurrent intranasal corticosteroid does not cause rebound and can reverse established tachyphylaxis. The Rebound Rescue protocol turns that evidence into a supervised, 90-day taper.
Peer-reviewed anchors
Vaidyanathan 2010, Am J Respir Crit Care Med · Randomized, double-blind crossover
After oxymetazoline-induced tachyphylaxis, three days of added fluticasone reversed it (PNIF +45 L/min; curve shift +26.2 L/min, p < 0.001); the effect localized to alpha-1 receptors.
View source →Baroody 2011, J Allergy Clin Immunol, n=60 · Randomized, double-blind, placebo-controlled
Fluticasone furoate plus oxymetazoline beat fluticasone alone, with no rhinitis medicamentosa in any arm over four weeks and none two weeks post-treatment.
View source →Thongngarm 2016, Asian Pac J Allergy Immunol · Randomized controlled trial
Adding oxymetazoline to INCS plus cetirizine improved congestion (p = 0.034) with no rebound two weeks after discontinuation.
View source →Fisher & Fishman 2022, 838 patients · Systematic review
Across the literature, concurrent INCS with oxymetazoline does not produce rebound. The safety conclusion is now review-level.
Citation on file
10 RCTs, 400+ participants · Systematic review and meta-analysis
Saline irrigation produced a 27.7% improvement in nasal symptoms and a 62.1% reduction in medication consumption, well tolerated.
Citation on file
Allermi data, observational
98.0%
of 352 patients with physician-confirmed rhinitis medicamentosa reported improvement (345/352; p < 0.0001).
96.0%
of 2,072 patients with documented prior oxymetazoline use reported improved congestion.
These data are observational and are presented as supplementary to the peer-reviewed evidence above.
Patient voices
“I fought to get off Afrin numerous times and always relapsed. With this I breathe freely most all day, every day, with no rebound.”
“Severe allergies and rebound congestion are finally properly medicated. I've discontinued the other sprays I was overusing.”
Individual results vary. Verified patient reviews.
Referral takes a minute. You stay the treating clinician; Allermi handles the telehealth evaluation and dispensing.
